GWS
VTVT icon

Glassman Wealth Services’s vTv Therapeutics VTVT Stock Holding History

Glassman Wealth Services’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Hold
0
– – – 2030
2022
Q1 		– Hold
0
– – – 1974
2019
Q2 		– Sell
-33
Closed -$2K – 1386
2019
Q1 		$2K Buy
+33
New +$3.2K ﹤0.01% 729

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Glassman Wealth Services's VTVT Position: Q2 2022 in Review

Glassman Wealth Services held its vTv Therapeutics (VTVT) position steady in Q2 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Glassman Wealth Services first reported a position in VTVT in Q1 2019 and has held it in 1 quarter since. The position peaked at $2K in Q1 2019. 23 funds tracked by Wall St. Rank hold VTVT as of Q2 2022.

  • Glassman Wealth Services held 0 shares of vTv Therapeutics worth $0 as of Q2 2022.
  • Glassman Wealth Services left its vTv Therapeutics share count unchanged in Q2 2022.
  • vTv Therapeutics made up ﹤0.01% of Glassman Wealth Services's portfolio in Q2 2022, its #2030 holding.
  • Glassman Wealth Services first reported a position in vTv Therapeutics in Q1 2019 and has held it in 1 quarter since.
  • Glassman Wealth Services's vTv Therapeutics position peaked at $2K in Q1 2019.
  • 23 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.